Dachaigh › Lymphoma Hodgkin › New Jersey
Sgrùdaidhean clionaigeach Lymphoma Hodgkin ann an New Jersey
Tha 5 sgrùdaidhean airson Lymphoma Hodgkin a’ lorg phàirtichean aig làraichean ann an New Jersey.
Bailtean ann an New Jersey
Teacsa sgrùdaidh oifigeil (Beurla)
Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma
- Memorial Sloan Kettering Basking Ridge, Basking Ridge
- Memorial Sloan Kettering Monmouth, Middletown
- Memorial Sloan Kettering Bergen, Montvale
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 24 Sult 2026 · NCT03618550A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Hackensack University Medical Center, Hackensack
- Robert Wood Johnson/Cancer Institute of New Jersey, New Brunswick
A’ fastadhSgrùdadh amharc
Gach aois · Gach gnè · Air ùrachadh 6 Iuch 2026 · NCT01351545Patient-Reported Outcomes and Quality of Life in Adult and Pediatric Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
- Hackensack University Medical Center, Hackensack
A’ fastadhSgrùdadh amharc
Aoisean 8 agus nas sine · Gach gnè · Air ùrachadh 20 Cèit 2026 · NCT06098430A Study of BV-AVD in People With Bulky Hodgkin Lymphoma
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 23 Gibl 2026 · NCT06377566Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma
- Memorial Sloan Kettering Basking Ridge, Basking Ridge
- Memorial Sloan Kettering Monmouth, Middletown
- Memorial Sloan Kettering Bergen, Montvale
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 4 Màrt 2026 · NCT01788839Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.